95 phenotypes from 9 alleles in 9 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Arxtm1.1Ics/Y involves: 129S2/SvPas * C57BL/6J * C57BL/6N	abnormal brain interneuron morphology	J:262482
	abnormal gait	J:262482
	abnormal nervous system electrophysiology	J:262482
	abnormal neuronal migration	J:262482
	abnormal voluntary movement	J:262482
	decreased neuron number	J:262482
	enhanced coordination	J:262482
	impaired balance	J:262482
	impaired contextual conditioning behavior	J:262482
	increased locomotor activity	J:262482
	increased vertical activity	J:262482
	muscle spasm	J:262482
Arxtm1.1Jno/Y involves: 129S7/SvEvBrd * C57BL/6J	abnormal associative learning	J:151082
	abnormal brain interneuron morphology	J:151082
	abnormal brain wave pattern	J:151082
	abnormal cerebral cortex morphology	J:151082
	abnormal hippocampus CA4 region morphology	J:151082
	abnormal somatosensory cortex morphology	J:151082
	abnormal striatum morphology	J:151082
	clonic seizures	J:151082
	decreased aggression towards mice	J:151082
	decreased anxiety-related response	J:151082
	decreased thermal nociceptive threshold	J:151082
	normal endocrine/exocrine gland phenotype	J:151082
	enhanced coordination	J:151082
	impaired contextual conditioning behavior	J:151082
	impaired cued conditioning behavior	J:151082
	myoclonus	J:151082
	seizures	J:151082
	tonic-clonic seizures	J:151082
Arxtm1.1Jno/Arxtm1.1Jno involves: 129S7/SvEvBrd * C57BL/6J	normal endocrine/exocrine gland phenotype	J:151082
	myoclonus	J:151082
Arxtm1Gldn/Y involves: 129/Sv * C57BL/6	no abnormal phenotype detected	J:138839
Arxtm1Gldn/Arx+ Tg(mI56i-cre,EGFP)1Kc/0 involves: 129/Sv * C57BL/6 * CD-1 * FVB/N	abnormal brain interneuron morphology	J:148311
	abnormal brain wave pattern	J:148311
	clonic seizures	J:148311
	convulsive seizures	J:148311
	normal nervous system phenotype	J:148311
	sporadic seizures	J:148311
	tonic-clonic seizures	J:148311
Arxtm1Gldn/Arxtm1Gldn involves: 129/Sv * C57BL/6	no abnormal phenotype detected	J:138839
Arxtm1Gldn/Y Tg(mI56i-cre,EGFP)1Kc/0 involves: 129/Sv * C57BL/6 * CD-1 * FVB/N	abnormal brain interneuron morphology	J:148311
	abnormal brain wave pattern	J:148311
	clonic seizures	J:148311
	decreased survivor rate	J:148311
	normal nervous system phenotype	J:148311
	postnatal lethality, incomplete penetrance	J:148311
	sporadic seizures	J:148311
	tonic-clonic seizures	J:148311
Arxtm1Gldn/Y Tg(Pou3f4-cre)32Cren/0 involves: 129/Sv * C57BL/6 * CD-1	abnormal cerebral cortex morphology	J:138839
	abnormal olfactory bulb morphology	J:138839
	decreased brain size	J:138839
Arxtm1Kki/Y involves: 129P2/OlaHsd * C57BL	abnormal brain internal capsule morphology	J:79871
	abnormal central medial nucleus morphology	J:79871
	abnormal corpus callosum morphology	J:79871
	abnormal cortical marginal zone morphology	J:79871
	abnormal cortical plate morphology	J:79871
	abnormal cortical ventricular zone morphology	J:79871
	abnormal dentate gyrus morphology	J:79871
	abnormal fetal Leydig cell differentiation	J:79871
	abnormal forebrain development	J:79871
	abnormal glutaminergic neuron morphology	J:79871
	abnormal hippocampus CA3 region morphology	J:79871
	abnormal hippocampus development	J:79871
	abnormal neocortex morphology	J:79871
	abnormal nervous system tract morphology	J:79871
	abnormal neuronal migration	J:79871
	abnormal olfactory bulb morphology	J:79871
	abnormal telencephalon development	J:79871
	abnormal telencephalon morphology	J:79871
	abnormal thalamus morphology	J:79871
	absent hippocampal commissure	J:79871
	absent hippocampal fimbria	J:79871
	decreased brain size	J:79871
	enlarged seminiferous tubules	J:79871
	enlarged third ventricle	J:79871
	neonatal lethality, complete penetrance	J:79871
	seminal vesicle hypoplasia	J:79871
	small olfactory bulb	J:79871
	small testis	J:79871
	thin cortical plate	J:79871
Arxtm1Pgr/Y involves: 129/Sv * NMRI	abnormal pancreatic delta cell morphology	J:86206
	absent pancreatic alpha cells	J:86206
	dehydration	J:86206
	hypoglycemia	J:86206
	increased pancreatic beta cell number	J:86206
	increased pancreatic delta cell number	J:86206
	postnatal growth retardation	J:86206
	postnatal lethality, complete penetrance	J:86206
	weakness	J:86206
Arxtm2Kki/Y involves: 129S/SvEv * C57BL/6J	abnormal neuronal migration	J:152416
	abnormal postnatal subventricular zone morphology	J:152416
	abnormal ventral striatum morphology	J:152416
	decreased brain size	J:152416
	neonatal lethality, complete penetrance	J:152416
	small olfactory bulb	J:152416
	thin cortical plate	J:152416
Arxtm3Kki/Y involves: 129S/SvEv * C57BL/6J	abnormal cholinergic neuron morphology	J:152416
	abnormal neuronal migration	J:152416
	abnormal spatial learning	J:152416
	hyperactivity	J:152416
	impaired coordination	J:152416
	impaired passive avoidance behavior	J:152416
	increased anxiety-related response	J:152416
	increased susceptibility to induced morbidity/mortality	J:152416
	increased susceptibility to pharmacologically induced seizures	J:152416
	loss of GABAergic neurons	J:152416
	normal mortality/aging	J:152416
Arxtm4Kki/Y involves: 129S/SvEv * C57BL/6J	abnormal cholinergic neuron morphology	J:152416
	abnormal neuronal migration	J:152416
	abnormal spatial learning	J:152416
	abnormal spike wave discharge	J:152416
	hyperactivity	J:152416
	impaired coordination	J:152416
	impaired passive avoidance behavior	J:152416
	increased anxiety-related response	J:152416
	loss of GABAergic neurons	J:152416
	premature death	J:152416
	seizures	J:152416
	tonic seizures	J:152416
Arxtm4Kki/Y involves: 129S/SvEv * C57BL/6NHsd	abnormal motor capabilities/coordination/movement	J:260340
	abnormal response to social novelty	J:260340
	abnormal social investigation	J:260340
	decreased body weight	J:260340
	decreased exploration in new environment	J:260340
	decreased fear-related response	J:260340
	decreased locomotor activity	J:260340
	impaired spatial learning	J:260340
	increased anxiety-related response	J:260340
	increased exploration in new environment	J:260340
	myoclonus	J:260340
	postnatal lethality, incomplete penetrance	J:260340
	premature death	J:260340
	social withdrawal	J:260340
Arxtm5Kki/Y involves: 129S/SvEv * C57BL/6J	abnormal brain interneuron morphology	J:152416
	normal nervous system phenotype	J:152416
Arxtm5Kki/Y involves: 129S/SvEv * C57BL/6NHsd	abnormal motor capabilities/coordination/movement	J:260340
	abnormal response to social novelty	J:260340
	abnormal social investigation	J:260340
	decreased body weight	J:260340
	decreased exploration in new environment	J:260340
	decreased fear-related response	J:260340
	decreased locomotor activity	J:260340
	impaired spatial learning	J:260340
	increased anxiety-related response	J:260340
	increased exploration in new environment	J:260340
	myoclonus	J:260340
	postnatal lethality, incomplete penetrance	J:260340
	premature death	J:260340
	seizures	J:260340
	social withdrawal	J:260340